Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Weerasuriya

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
The Ceylon Medical Journal|March 17, 2006
Cataracts, health technology and the spectacle of reversely abled generationsK Weerasuriya
The International Journal of Risk & Safety in Medicine|March 21, 2013
Globalisation of drug regulation and drug regulators in developing countriesGroping in the dark even when there is a light switch; an example from Sri LankaK Weerasuriya
The Ceylon Medical Journal|October 29, 2000
Cost-effective drugs? It depends on what door is chosenK Weerasuriya
The Ceylon Medical Journal|September 1, 1991
Management of mild or moderate hypertension is simpleK Weerasuriya
The Ceylon Medical Journal|June 13, 1998
Mass murderersK Weerasuriya
Lancet (London, England)|September 16, 1998
Mibefradil: the sole exceptionK Weerasuriya
Lancet (London, England)|December 10, 1988
Indigenised pharmaceuticalsK Weerasuriya
Lancet (London, England)|January 19, 1991
IFPMA code on advertisingK Weerasuriya
Lancet (London, England)|June 26, 1999
Registration of new drugs in developing countriesK Weerasuriya
Bulletin of the World Health Organization|January 1, 1993
Essential drugs and registration of pharmaceuticals: the Sri Lankan experienceK Weerasuriya
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
The Ceylon Medical Journal|March 17, 2006
Cataracts, health technology and the spectacle of reversely abled generationsK Weerasuriya
The International Journal of Risk & Safety in Medicine|March 21, 2013
Globalisation of drug regulation and drug regulators in developing countriesGroping in the dark even when there is a light switch; an example from Sri LankaK Weerasuriya
The Ceylon Medical Journal|October 29, 2000
Cost-effective drugs? It depends on what door is chosenK Weerasuriya
The Ceylon Medical Journal|September 1, 1991
Management of mild or moderate hypertension is simpleK Weerasuriya
The Ceylon Medical Journal|June 13, 1998
Mass murderersK Weerasuriya
Lancet (London, England)|September 16, 1998
Mibefradil: the sole exceptionK Weerasuriya
Lancet (London, England)|December 10, 1988
Indigenised pharmaceuticalsK Weerasuriya
Lancet (London, England)|January 19, 1991
IFPMA code on advertisingK Weerasuriya
Lancet (London, England)|June 26, 1999
Registration of new drugs in developing countriesK Weerasuriya
Bulletin of the World Health Organization|January 1, 1993
Essential drugs and registration of pharmaceuticals: the Sri Lankan experienceK Weerasuriya
Pageof 6